Skip to main content
. 2021 Jul 18;13(14):3594. doi: 10.3390/cancers13143594

Table 6.

Severe morbidity according to the different inflammatory and immune-nutritional markers.

Prognostic Marker Univariate Analysis Logistic Regression
n (%) p Values OR 95% C.I. p Values
GPS 0 27/192 (14.1) <0.001 3.889 2.161–6.998 <0.001
1–2 35/90 (38.9)
mGPS 0 39/214 (18.2) 0.007 2.293 1.245–4.223 0.008
1–2 23/68 (33.8)
PI 0 36/200 (18.0) 0.010 2.115 1.174–3.810 0.013
1–2 26/82 (31.7)
NLR <3.13 22/146 (15.1) 0.003 2.348 1.309–4.213 0.004
≥3.13 40/136 (29.4)
PLR <178.2 28/174 (16.1) 0.002 2.396 1.351–4.249 0.003
≥178.2 34/108 (31.5)
LMR ≥3.47 22/126 (17.5) 0.066 1.630 0.909–2.922 0.101
<3.47 40/156 (25.6)
PNI ≥48.6 16/154 (10.4) <0.001 4.838 2.574–9.095 <0.001
<48.6 46/128 (35.9)

GPS, Glasgow Prognostic Score; mGPS, modified Glasgow Prognostic Score; PI, Prognostic Index; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; PNI, prognostic nutritional index.